Exact Mass: 299.1845

Exact Mass Matches: 299.1845

Found 466 metabolites which its exact mass value is equals to given mass value 299.1845, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

indicine

BUTANOIC ACID, 2,3-DIHYDROXY-2-(1-METHYLETHYL)-, (2,3,5,7A-TETRAHYDRO-1-HYDROXY-1H-PYRROLIZIN-7-YL)METHYL ESTER, (1S-(1.ALPHA.,7(2R*,3S*),7A.ALPHA.))-

C15H25NO5 (299.1733)


Rinderine is a member of pyrrolizines. Rinderine is a natural product found in Chromolaena odorata, Eupatorium japonicum, and other organisms with data available.

   

N-Methylcoclaurine

7-Isoquinolinol, 1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-, (1R)-

C18H21NO3 (299.1521)


(R)-N-methylcoclaurine is the (R)-enantiomer of N-methylcoclaurine. It is a conjugate base of a (R)-N-methylcoclaurinium. It is an enantiomer of a (S)-N-methylcoclaurine. (R)-N-Methylcoclaurine is a natural product found in Cyclea barbata, Cyclea peltata, and other organisms with data available.

   

Codeine

(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-14-ol

C18H21NO3 (299.1521)


In the United States, codeine is regulated by the Controlled Substances Act. It is a Schedule II controlled substance for pain-relief products containing codeine alone. In combination with aspirin or acetaminophen (paracetamol/tylenol) it is listed as Schedule III. Codeine is also available outside the United States as an over-the-counter drug (Schedule V) in liquid cough-relief formulations. Internationally, codeine is a Schedule II drug under the Single Convention on Narcotic Drugs. In the United Kingdom, codeine is regulated by the Misuse of Drugs Act 1971; it is a Class B Drug, except for concentrations of less than 8mg when combined with paracetamol - or 12.5mg when combined with ibuprofen - which are available in many over the counter preparations. it is a Class B Drug, except for concentrations of less than 8mg when combined with paracetamol - or 12.5mg when combined with ibuprofen - which are available in many over the counter preparations. An opioid analgesic related to morphine but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough. Codeine or methylmorphine is an opiate used for its analgesic, antitussive and antidiarrheal properties. It is marketed as the salts codeine sulfate and codeine phosphate. Codeine hydrochloride is more commonly marketed in contintental Europe and other regions. Codeine is an alkaloid found in opium in concentrations ranging from 0.3 to 3.0 percent. While codeine can be extracted from opium, most codeine is synthesized from morphine through the process of O-methylation. In the United Kingdom, codeine is regulated by the Misuse of Drugs Act 1971; Codeine or methylmorphine is an opiate used for its analgesic, antitussive and antidiarrheal properties. It is marketed as the salts codeine sulfate and codeine phosphate. Codeine hydrochloride is more commonly marketed in contintental Europe and other regions. Codeine is an alkaloid found in opium in concentrations ranging from 0.3 to 3.0 percent. While codeine can be extracted from opium, most codeine is synthesized from morphine through the process of O-methylation. Theoretically, a dose of approximately 200 mg (oral) of codeine must be administered to give equivalent analgesia to 30 mg (oral) of morphine (Rossi, 2004). It is not used, however, in single doses of greater than 60mg (and no more than 240 mg in 24 hours) since there is a ceiling effect. [PubChem]Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Codeines analgesic activity is, most likely, due to its conversion to morphine. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability. R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Opium alkaloid (Papaver somniferum) (content ca. 1\\%) CONFIDENCE standard compound; INTERNAL_ID 1623

   

Metoclopramide

4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide

C14H22ClN3O2 (299.14)


Metoclopramide is only found in individuals that have used or taken this drug. It is a dopamine D2 antagonist that is used as an antiemetic. [PubChem]Metoclopramide inhibits gastric smooth muscle relaxation produced by dopamine, therefore increasing cholinergic response of the gastrointestinal smooth muscle. It accelerates intestinal transit and gastric emptying by preventing relaxation of gastric body and increasing the phasic activity of antrum. Simultaneously, this action is accompanied by relaxation of the upper small intestine, resulting in an improved coordination between the body and antrum of the stomach and the upper small intestine. Metoclopramide also decreases reflux into the esophagus by increasing the resting pressure of the lower esophageal sphincter and improves acid clearance from the esophagus by increasing amplitude of esophageal peristaltic contractions. Metoclopramides dopamine antagonist action raises the threshold of activity in the chemoreceptor trigger zone and decreases the input from afferent visceral nerves. Studies have also shown that high doses of metoclopramide can antagonize 5-hydroxytryptamine (5-HT) receptors in the peripheral nervous system in animals. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics EAWAG_UCHEM_ID 2781; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 2781 D002491 - Central Nervous System Agents

   

Hydrocodone

(1S,5R,13R,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-14-one

C18H21NO3 (299.1521)


Hydrocodone is only found in individuals that have used or taken this drug. It is a narcotic analgesic related to codeine, but more potent and more addicting by weight. It is used also as cough suppressant. [PubChem]Hydrocodone acts as a weak agonist at OP1, OP2, and OP3 opiate receptors within the central nervous system (CNS). Hydrocodone primarily affects OP3 receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as hydrocodone also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability. R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

(S)-N-Methylcoclaurine

(S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2- methyl-7-isoquinolinol

C18H21NO3 (299.1521)


This compound belongs to the family of Benzylisoquinolines. These are organic compounds containing an isoquinoline to which a benzyl group is attached.

   

Neopine

10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,16-tetraen-14-ol

C18H21NO3 (299.1521)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids Neopine is found in opium poppy. Minor alkaloid of opium (Papaver somniferum

   

Isolycopsamine

Isolycopsamine

C15H25NO5 (299.1733)


   

Heterocodeine

Morphine, O(sup6)-methyl-

C18H21NO3 (299.1521)


   

Ethylketocyclazocine

Ethylketocyclazocine

C19H25NO2 (299.1885)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

NCIOpen2_003510

3-Hydroxyestra-1,3,5(10)-triene-16,17-dione 16-oxime

C18H21NO3 (299.1521)


   

Lycopsamine

[(1R,7aR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO5 (299.1733)


Lycopsamine, also known as indicine or 9-viridiflorylretronecine, belongs to alkaloids and derivatives class of compounds. Those are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic propertiesand is also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus. Lycopsamine is soluble (in water) and a very weakly acidic compound (based on its pKa). Lycopsamine can be found in borage, which makes lycopsamine a potential biomarker for the consumption of this food product. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2270

   

intermedine

9-(+)-Trachelanthylretronecine

C15H25NO5 (299.1733)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2293

   

2-Undecyl-4(1H)-quinolinone

2-undecyl-1,4-dihydroquinolin-4-one

C20H29NO (299.2249)


2-Undecyl-4(1H)-quinolinone is found in herbs and spices. 2-Undecyl-4(1H)-quinolinone is an alkaloid from and roots of Ruta graveolens (rue) (as the main component of an inseparable mixture of 2-alkylquinolones contg. the 2-dodecyl, 2-tridecyl and 2-tetradecyl homologues) (Rutaceae). Alkaloid from and roots of Ruta graveolens (rue) (as the main component of an inseparable mixture of 2-alkylquinolones contg. the 2-dodecyl, 2-tridecyl and 2-tetradecyl homologues) (Rutaceae). 2-Undecyl-4(1H)-quinolinone is found in herbs and spices.

   

Erysodine

(1S,16R)-4,16-dimethoxy-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),3,5,12,14-pentaen-5-ol

C18H21NO3 (299.1521)


Erysodine is found in green vegetables. Erysodine is an alkaloid from Erythrina fusca (gallito

   

(R)-Juziphine

1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-ol

C18H21NO3 (299.1521)


(R)-Juziphine is found in fruits. (R)-Juziphine is an alkaloid from the leaves of Zizyphus jujuba (Chinese date). Alkaloid from the leaves of Zizyphus jujuba (Chinese date). (R)-Juziphine is found in fruits.

   

Pandamarilactone 32

1-{4-[(2E)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}-6-methylidene-1H,2H,3H,4H,5H,6H,7H-cyclopenta[b]pyridin-5-one

C18H21NO3 (299.1521)


Pandamarilactone 32 is a food flavouring. Pandamarilactone 32 is a major alkaloid from leaves of Pandanus amaryllifolius. Food flavouring. Major alkaloid from leaves of Pandanus amaryllifolius

   

Secoclausenamide

2,3-dihydroxy-N-methyl-3-phenyl-N-(2-phenylethyl)propanamide

C18H21NO3 (299.1521)


Secoclausenamide is found in fruits. Secoclausenamide is an alkaloid from Clausena lansium (wampee). Alkaloid from Clausena lansium (wampee). Secoclausenamide is found in fruits.

   

(2E,6E)-Piperamide-C7:2

(2E,6Z)-7-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)hepta-2,6-dien-1-one

C18H21NO3 (299.1521)


(2E,6E)-Piperamide-C7:2 is found in herbs and spices. (2E,6E)-Piperamide-C7:2 is a constituent of the fruits of pepper (Piper nigrum) and cha-plu (Piper sarmentosum) (Piperaceae). Constituent of the fruits of pepper (Piper nigrum) and cha-plu (Piper sarmentosum) (Piperaceae). (2E,6E)-Piperamide-C7:2 is found in herbs and spices and pepper (spice).

   

2-(3-carboxy-3-(trimethylammonio)propyl)-L-histidine

(3-{4-[(2S)-2-amino-2-carboxyethyl]-3H-imidazol-2-yl}-1-carboxypropyl)trimethylazanium

C13H23N4O4+ (299.1719)


2-(3-carboxy-3-(trimethylammonio)propyl)-l-histidine is part of the Protein modification pathway. It is a substrate for: Diphthine synthase.

   

Diphthine

[(1R)-3-{5-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-2-yl}-1-carboxypropyl]trimethylazanium

C13H23N4O4+ (299.1719)


This compound belongs to the family of Alpha Amino Acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon).

   

N-depropylpropafenone

1-[2-(3-amino-2-hydroxypropoxy)phenyl]-3-phenylpropan-1-one

C18H21NO3 (299.1521)


N-depropylpropafenone is a metabolite of propafenone. Propafenone is a class of anti-arrhythmic medication, which treats illnesses associated with rapid heart beats such as atrial and ventricular arrhythmias. (Wikipedia)

   

Thiazinamium

trimethyl[1-(10H-phenothiazin-10-yl)propan-2-yl]azanium

C18H23N2S+ (299.1582)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Thiazinamium is a first-generation phenothiazine H1-antihistamine.

   

2,3-dimethylidenepentanedioylcarnitine

3-[(4-carboxy-2,3-dimethylidenebutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H21NO6 (299.1369)


2,3-dimethylidenepentanedioylcarnitine is an acylcarnitine. More specifically, it is an 2,3-dimethylidenepentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2,3-dimethylidenepentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2,3-dimethylidenepentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyocta-2,5-dienoylcarnitine

3-[(3-hydroxyocta-2,5-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO5 (299.1733)


3-hydroxyocta-2,5-dienoylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyocta-2,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyocta-2,5-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyocta-2,5-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyocta-2,6-dienoylcarnitine

3-[(3-hydroxyocta-2,6-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO5 (299.1733)


3-hydroxyocta-2,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyocta-2,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyocta-2,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyocta-2,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyocta-3,6-dienoylcarnitine

3-[(3-hydroxyocta-3,6-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO5 (299.1733)


3-hydroxyocta-3,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyocta-3,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyocta-3,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyocta-3,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyocta-2,4-dienoylcarnitine

3-[(3-Hydroxyocta-2,4-dienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H25NO5 (299.1733)


3-hydroxyocta-2,4-dienoylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyocta-2,4-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyocta-2,4-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyocta-2,4-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z,6Z)-3-Hydroxyocta-4,6-dienoylcarnitine

3-[(3-Hydroxyocta-4,6-dienoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H25NO5 (299.1733)


(4Z,6Z)-3-hydroxyocta-4,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an (4Z,6Z)-3-hydroxyocta-4,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z,6Z)-3-hydroxyocta-4,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4Z,6Z)-3-hydroxyocta-4,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyocta-3,5-dienoylcarnitine

3-[(3-hydroxyocta-3,5-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO5 (299.1733)


3-hydroxyocta-3,5-dienoylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyocta-3,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyocta-3,5-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyocta-3,5-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z)-Non-2-enoylcarnitine

3-(Non-2-enoyloxy)-4-(trimethylazaniumyl)butanoic acid

C16H29NO4 (299.2096)


(2Z)-non-2-enoylcarnitine is an acylcarnitine. More specifically, it is an (2Z)-non-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z)-non-2-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2Z)-non-2-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Non-4-enoylcarnitine

3-(non-4-enoyloxy)-4-(trimethylazaniumyl)butanoate

C16H29NO4 (299.2096)


Non-4-enoylcarnitine is an acylcarnitine. More specifically, it is an non-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Non-5-enoylcarnitine

3-(non-5-enoyloxy)-4-(trimethylazaniumyl)butanoate

C16H29NO4 (299.2096)


Non-5-enoylcarnitine is an acylcarnitine. More specifically, it is an non-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-5-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-5-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Non-3-enoylcarnitine

3-(Non-3-enoyloxy)-4-(trimethylazaniumyl)butanoic acid

C16H29NO4 (299.2096)


Non-3-enoylcarnitine is an acylcarnitine. More specifically, it is an non-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-3-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-3-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Non-7-enoylcarnitine

3-(non-7-enoyloxy)-4-(trimethylazaniumyl)butanoate

C16H29NO4 (299.2096)


Non-7-enoylcarnitine is an acylcarnitine. More specifically, it is an non-7-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-7-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-7-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Non-6-enoylcarnitine

3-(Non-6-enoyloxy)-4-(trimethylazaniumyl)butanoic acid

C16H29NO4 (299.2096)


Non-6-enoylcarnitine is an acylcarnitine. More specifically, it is an non-6-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-6-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-6-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(+/-)-Ethylketocyclazocine

10-(cyclopropylmethyl)-1-ethyl-4-hydroxy-13-methyl-10-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5-trien-8-one

C19H25NO2 (299.1885)


   

(1R,9S)-10-(Cyclopropylmethyl)-12-ethyl-4-hydroxy-13-methyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one

(1R,9S)-10-(Cyclopropylmethyl)-12-ethyl-4-hydroxy-13-methyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one

C19H25NO2 (299.1885)


   

Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-

10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),15-tetraen-14-ol

C18H21NO3 (299.1521)


   

1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine

1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine

C19H25NS (299.1708)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Benz(cd)indole-6-carboxamide, 4-(dipropylamino)-1,3,4,5-tetrahydro-

6-(dipropylamino)-2-azatricyclo[6.3.1.0^{4,12}]dodeca-1(12),3,8,10-tetraene-9-carboxamide

C18H25N3O (299.1998)


   

3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide

3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide

C20H29NO (299.2249)


   

Indicine

(1-Hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl 2,3-dihydroxy-2-(propan-2-yl)butanoic acid

C15H25NO5 (299.1733)


   

3-Pyridinemethanol, 6-amino-alpha-(((1-methyl-4-phenylbutyl)amino)methyl)-

3-Pyridinemethanol, 6-amino-alpha-(((1-methyl-4-phenylbutyl)amino)methyl)-

C18H25N3O (299.1998)


   

Nylidrin

4-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]propyl}phenol

C19H25NO2 (299.1885)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AA - 2-amino-1-phenylethanol derivatives D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

(4R,4Ar,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,7a,11a,12a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

(4R,4Ar,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,7a,11a,12a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

C18H21NO3 (299.1521)


   

Magnococline

2,2-Didemethylpetaline

C18H21NO3 (299.1521)


   

cyclo(D-Ile-L-Trp)

cyclo(D-Ile-L-Trp)

C17H21N3O2 (299.1634)


   

cyclo-L-Trp-L-Leu

cyclo-L-Trp-L-Leu

C17H21N3O2 (299.1634)


   

Cocculidinone

Cocculidinone

C18H21NO3 (299.1521)


   

4-O-Methylcoclaurine

(-)-4-O-Methylcoclaurine

C18H21NO3 (299.1521)


   

3-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]phenol

3-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]phenol

C18H21NO3 (299.1521)


   

dl-N-Norarmepavine

dl-N-Norarmepavine

C18H21NO3 (299.1521)


   

2-(Nonan-8-one)-4-methoxy-quinoline

2-(Nonan-8-one)-4-methoxy-quinoline

C19H25NO2 (299.1885)


   

DTXSID10707391

DTXSID10707391

C19H25NO2 (299.1885)


   
   

8,9-Dihydrostepharine

8,9-Dihydrostepharine

C18H21NO3 (299.1521)


   
   

DTXSID80726716

DTXSID80726716

C18H21NO3 (299.1521)


   
   

ATISINE, AZOMETHINE

ATISINE, AZOMETHINE

C20H29NO (299.2249)


   

(+)-8,9-Dihydrostepharine

(+)-8,9-Dihydrostepharine

C18H21NO3 (299.1521)


   

(R)-N-Methylcoclaurine

(R)-N-Methylcoclaurine

C18H21NO3 (299.1521)


   

7-O-Methylcoclaurine

7-O-Methylcoclaurine

C18H21NO3 (299.1521)


   

25H-NBOMe imine analog

25H-NBOMe imine analog

C18H21NO3 (299.1521)


   
   
   

Dehydroabietamide

Dehydroabietamide

C20H29NO (299.2249)


   
   

N-(3-Hydroxydodecanoyl)-DL-homoserine lactone

N-(3-Hydroxydodecanoyl)-DL-homoserine lactone

C16H29NO4 (299.2096)


   

nylidrin

nylidrin

C19H25NO2 (299.1885)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AA - 2-amino-1-phenylethanol derivatives D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents CONFIDENCE standard compound; INTERNAL_ID 6; HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) INTERNAL_ID 6; CONFIDENCE standard compound; HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)

   

(+-)-11,12-Dihydroglaziovine [French]

(+-)-11,12-Dihydroglaziovine [French]

C18H21NO3 (299.1521)


   

6-Methoxy-2-(4-methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-7-ol

6-Methoxy-2-(4-methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-7-ol

C18H21NO3 (299.1521)


   

Haminol C|Haminol-C

Haminol C|Haminol-C

C19H25NO2 (299.1885)


   

(+-)-7,8,9-trimethyl-eleocarpine|(+-)-Elaeocarpin|6a,11,12a,12b-tetramethyl-(6ar,12at,12bc)-1,2,3,5,6,6a,12a,12b-octahydro-chromeno[2,3-g]indolizin-12-one

(+-)-7,8,9-trimethyl-eleocarpine|(+-)-Elaeocarpin|6a,11,12a,12b-tetramethyl-(6ar,12at,12bc)-1,2,3,5,6,6a,12a,12b-octahydro-chromeno[2,3-g]indolizin-12-one

C19H25NO2 (299.1885)


   

tetradeca-2t,6t,8t-12c-tetraen-10-ynoic isobutyl amide

tetradeca-2t,6t,8t-12c-tetraen-10-ynoic isobutyl amide

C20H29NO (299.2249)


   

3,4-Dihydro,1-hydroxy-Dictyolomide A|dictylomide B

3,4-Dihydro,1-hydroxy-Dictyolomide A|dictylomide B

C19H25NO2 (299.1885)


   

(+)-dihydromecambrinol-D|(-)-Roemeramin|(1S)-3-methyl-(1rC2,1rC2,2ac)-2a,3,4,5-tetrahydro-2H-spiro[cyclohex-2-ene-1,1-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-4t-ol|remeramine|roemeramine

(+)-dihydromecambrinol-D|(-)-Roemeramin|(1S)-3-methyl-(1rC2,1rC2,2ac)-2a,3,4,5-tetrahydro-2H-spiro[cyclohex-2-ene-1,1-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-4t-ol|remeramine|roemeramine

C18H21NO3 (299.1521)


   
   

Veatchine azomethine

Veatchine azomethine

C20H29NO (299.2249)


   

(2E,6E,8E)-2,6,8-Hexadecatrien-10-insaeure-pyrrolidid

(2E,6E,8E)-2,6,8-Hexadecatrien-10-insaeure-pyrrolidid

C20H29NO (299.2249)


   

chaerophylline

chaerophylline

C18H21NO3 (299.1521)


   

hexadeca-9Z-en-10-ynoic acid pyrrolide

hexadeca-9Z-en-10-ynoic acid pyrrolide

C20H29NO (299.2249)


   

Tetrahydronitramarine

Tetrahydronitramarine

C20H17N3 (299.1422)


   

Komarovicine

Komarovicine

C20H17N3 (299.1422)


Origin: Plant; SubCategory_DNP: Alkaloids derived from tryptophan, beta-Carboline alkaloids, Indole alkaloids

   
   
   

12-O-methylcoclaurine

12-O-methylcoclaurine

C18H21NO3 (299.1521)


   

(2S,3S,6E)-N,N-dimethyl-2-[(R)-methylsulfinyl]tetradeca-6,13-dien-3-amine|(2S,3S,6E)-N,N-dimethyl-2-[(S)-methylsulfinyl]tetradeca-6,13-dien-3-amine|aplisulfamine A|aplisulfamine B

(2S,3S,6E)-N,N-dimethyl-2-[(R)-methylsulfinyl]tetradeca-6,13-dien-3-amine|(2S,3S,6E)-N,N-dimethyl-2-[(S)-methylsulfinyl]tetradeca-6,13-dien-3-amine|aplisulfamine A|aplisulfamine B

C17H33NOS (299.2283)


   
   

(3R,5S)-3-methyl-5-((5E)-pentadec-5-ene-7,9-diynyl)-pyrrolidin-2-one

(3R,5S)-3-methyl-5-((5E)-pentadec-5-ene-7,9-diynyl)-pyrrolidin-2-one

C20H29NO (299.2249)


   

1-Methyl-2-decylquinoline-4(1H)-one

1-Methyl-2-decylquinoline-4(1H)-one

C20H29NO (299.2249)


   

(+)-N-Methylisococlaurine

(+)-N-Methylisococlaurine

C18H21NO3 (299.1521)


   

(5-methoxy-2-methylisoindolin-1-yl)(4-methoxyphenyl)methanol

(5-methoxy-2-methylisoindolin-1-yl)(4-methoxyphenyl)methanol

C18H21NO3 (299.1521)


   

SR-01000318475

SR-01000318475

C18H21NO3 (299.1521)


   
   

2-Methylpropylamide-(2E,9Z)-2,9-Hexadecadiene-12,14-diynoic acid|hexadeca-2E,9Z-dien-12,14-diynoic acid isobutylamide

2-Methylpropylamide-(2E,9Z)-2,9-Hexadecadiene-12,14-diynoic acid|hexadeca-2E,9Z-dien-12,14-diynoic acid isobutylamide

C20H29NO (299.2249)


   

15,16-dimethoxy-1,6-didehydroerythrinan-2-one

15,16-dimethoxy-1,6-didehydroerythrinan-2-one

C18H21NO3 (299.1521)


   

Isosendaverine

Isosendaverine

C18H21NO3 (299.1521)


   

Haminol 6|Haminol-6

Haminol 6|Haminol-6

C19H25NO2 (299.1885)


   

1-Methyl-2-(8-oxononyl)quinoline-4(1H)-one

1-Methyl-2-(8-oxononyl)quinoline-4(1H)-one

C19H25NO2 (299.1885)


   

Tetrahydrokomarovinine

Tetrahydrokomarovinine

C20H17N3 (299.1422)


   

Haminol 2|haminol acetate|Haminol-2

Haminol 2|haminol acetate|Haminol-2

C19H25NO2 (299.1885)


   

Tetrahydroisokomarovine

Tetrahydroisokomarovine

C20H17N3 (299.1422)


   

SCHEMBL9488362

SCHEMBL9488362

C18H21NO3 (299.1521)


   
   

(+)-canelilline|(S)-form-Canelilline

(+)-canelilline|(S)-form-Canelilline

C18H21NO3 (299.1521)


   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-N-methyl-3-methyl-2-butenamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-N-methyl-3-methyl-2-butenamide

C19H25NO2 (299.1885)


   

Trachelanthamidine 2S-hydroxy-2S-(1S-hydroxyethyl)-4-methylpentanoyl ester

Trachelanthamidine 2S-hydroxy-2S-(1S-hydroxyethyl)-4-methylpentanoyl ester

C16H29NO4 (299.2096)


   

(3beta)-1,6-didehydro-3-methoxy-15,16-[methylenebis(oxy)]-erythrinan|3beta-methoxy-15,16-methanediyldioxy-erythrin-1(6)-ene|3beta-Methoxy-15,16-methylendioxy-erythrin-1(6)-en|3beta-methoxy-15,16-methylenedioxy-erythrin-1(6)-ene|Erythramin|erythramine

(3beta)-1,6-didehydro-3-methoxy-15,16-[methylenebis(oxy)]-erythrinan|3beta-methoxy-15,16-methanediyldioxy-erythrin-1(6)-ene|3beta-Methoxy-15,16-methylendioxy-erythrin-1(6)-en|3beta-methoxy-15,16-methylenedioxy-erythrin-1(6)-ene|Erythramin|erythramine

C18H21NO3 (299.1521)


   

(2E,7Z)-2,7-Hexadecadien-10-insaeure-(2,3-didehydropyrrolidid)|(2E,7Z)-2,7-Hexadecadien-10-insaeure-<2,3-didehydropyrrolidid>

(2E,7Z)-2,7-Hexadecadien-10-insaeure-(2,3-didehydropyrrolidid)|(2E,7Z)-2,7-Hexadecadien-10-insaeure-<2,3-didehydropyrrolidid>

C20H29NO (299.2249)


   

Viridiflorine

Viridiflorine

C16H29NO4 (299.2096)


   

1-(quinolin-4-yl)-1,2,3,4-tetrahydro-b-carboline

1-(quinolin-4-yl)-1,2,3,4-tetrahydro-b-carboline

C20H17N3 (299.1422)


   
   

(-)-Swainsonine triacetate|1,2,8-tri-O-acetylswainsonine|Acetic acid (1S,2R,8R,8aR)-1,2-diacetoxyoctahydroindolizin-8-yl ester|swainsonine triacetate|Swainsonintriacetat|tri-O-acetylswainsonine

(-)-Swainsonine triacetate|1,2,8-tri-O-acetylswainsonine|Acetic acid (1S,2R,8R,8aR)-1,2-diacetoxyoctahydroindolizin-8-yl ester|swainsonine triacetate|Swainsonintriacetat|tri-O-acetylswainsonine

C14H21NO6 (299.1369)


   

Haminol B|Haminol-B

Haminol B|Haminol-B

C19H25NO2 (299.1885)


   

glaciapyrrole C

glaciapyrrole C

C19H25NO2 (299.1885)


   
   
   
   
   
   
   

Intermedina

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, [(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl ester, (2S,3R)-; Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1R-[1?,7(2S*,3R*),7a?]]-; Intermedine (7CI,8CI); (+)-Intermedine; 3-epi-Lycopsamine

C15H25NO5 (299.1733)


Intermedine is a carboxylic ester compound formed from condensation between retronecine and (2S,3R)-2,3-dihydroxy-2-isopropylbutanoic acid. It is a member of pyrrolizines, an azabicycloalkane and a carboxylic ester. Intermedine is a natural product found in Eupatorium cannabinum, Chromolaena odorata, and other organisms with data available. See also: Comfrey Leaf (part of); Comfrey Root (part of).

   

indicine

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1R-[1?,7(2S*,3S*),7a?]]-; Lycopsamine (7CI,8CI); (+)-Lycopsamine; 3-epi-Intermedine; Retronecine 9-((-)-viridiflorate)

C15H25NO5 (299.1733)


Lycopsamine is a member of pyrrolizines. Lycopsamine is a natural product found in Brickellia grandiflora, Eupatorium cannabinum, and other organisms with data available. See also: Comfrey Leaf (part of); Comfrey Root (part of); Borage (part of).

   

Codeine

(-)-codeine

C18H21NO3 (299.1521)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives A morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics relative retention time with respect to 9-anthracene Carboxylic Acid is 0.308 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.294 IPB_RECORD: 924; CONFIDENCE confident structure CONFIDENCE standard compound; EAWAG_UCHEM_ID 2780

   

Hydrocodone

Hydrocodone

C18H21NO3 (299.1521)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3332

   

UHQ (mixed MS2 C11:db:UHQ)

UHQ (mixed MS2 C11:db:UHQ)

C20H29NO (299.2249)


   

PYR_300.1709_10.6

PYR_300.1709_10.6

C17H21N3O2 (299.1634)


CONFIDENCE Identification confirmed with Reference Standard synthesized at Eawag (Level 1); INTERNAL_ID 1710

   

N-Methylcoclaurine

N-Methylcoclaurine

C18H21NO3 (299.1521)


   

metoclopramide

metoclopramide

C14H22ClN3O2 (299.14)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents CONFIDENCE standard compound; INTERNAL_ID 10; HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE standard compound; INTERNAL_ID 2289

   

3-hydroxy-C12 homoserine lactone

3-Hydroxy-N-(2-oxotetrahydrofuran-3-yl)dodecanamide

C16H29NO4 (299.2096)


CONFIDENCE standard compound; INTERNAL_ID 217

   

N-Despropylpropafenone

N-Despropylpropafenone

C18H21NO3 (299.1521)


   

Rinderine

Rinderine

C15H25NO5 (299.1733)


Annotation level-1

   

echinatine

echinatine

C15H25NO5 (299.1733)


Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Pyrrolizidine alkaloids

   

nonylphenazolone

nonylphenazolone

C19H25NO2 (299.1885)


   
   
   
   
   
   
   
   
   
   
   
   
   

PC(O-2:0/O-1:0)

3,5,9-Trioxa-4-phosphaundecan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C11H26NO6P (299.1498)


   
   

Erysodine

(12R,13aS)-2,12-dimethoxy-5H,6H,8H,12H,13H-indolo[7a,1-a]isoquinolin-3-ol

C18H21NO3 (299.1521)


An erythrina alkaloid with formula C18H21NO3 isolated from several erythrina plant species. It is a competitive antagonist of nicotinic acetylcholine receptors and exhibits antiparasitic and insecticidal activities.

   

Secoclausenamide

2,3-dihydroxy-N-methyl-3-phenyl-N-(2-phenylethyl)propanamide

C18H21NO3 (299.1521)


   

4-Hydroxy-2-undecylquinoline

2-undecyl-1,4-dihydroquinolin-4-one

C20H29NO (299.2249)


   

Sarmentosine?

(2E,6Z)-7-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)hepta-2,6-dien-1-one

C18H21NO3 (299.1521)


   

Juziphine

1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-ol

C18H21NO3 (299.1521)


   

Pandamarilactone 32

1-{4-[(2E)-4-methyl-5-oxo-2,5-dihydrofuran-2-ylidene]butyl}-6-methylidene-1H,2H,3H,4H,5H,6H,7H-cyclopenta[b]pyridin-5-one

C18H21NO3 (299.1521)


   

2-(3-carboxy-3-(trimethylammonio)propyl)-L-histidine

(3-{5-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-2-yl}-1-carboxypropyl)trimethylazanium

C13H23N4O4 (299.1719)


   

3OH-C12-HSL

N-(3-hydroxy-dodecanoyl)-homoserine lactone

C16H29NO4 (299.2096)


   

CIS-6,9,12,15-OCTADECATETRAENOIC ACID*SO DIUM

CIS-6,9,12,15-OCTADECATETRAENOIC ACID*SO DIUM

C18H28NaO2 (299.1987)


   
   

7-Ethoxycarbonyl-9-(ethoxycarbonylmethyl)-9-azabicyclo[3,3,1]nonan-3-ol

7-Ethoxycarbonyl-9-(ethoxycarbonylmethyl)-9-azabicyclo[3,3,1]nonan-3-ol

C15H25NO5 (299.1733)


   

4-Cyanophenyl trans-4-pentylcyclohexanecarboxylate

4-Cyanophenyl trans-4-pentylcyclohexanecarboxylate

C19H25NO2 (299.1885)


   

Propinetidine

Propinetidine

C19H25NO2 (299.1885)


   

(-)-Tramadol Hydrochloride

(-)-tramadol, hydrochloride

C16H26ClNO2 (299.1652)


   

3-[4-[bis(2-hydroxyethyl)amino]-2-nitroanilino]propan-1-ol

3-[4-[bis(2-hydroxyethyl)amino]-2-nitroanilino]propan-1-ol

C13H21N3O5 (299.1481)


   

1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL)

1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL)

C16H21N5O (299.1746)


   

Nortriptyline Hydrochloride

Nortriptyline Hydrochloride

C19H22ClN (299.1441)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators Nortriptyline (Desmethylamitriptyline) hydrochloride, the main active metabolite of Amitriptyline, is a tricyclic antidepressant. Nortriptyline hydrochloride is a potent autophagy inhibitor and has anticancer effects[1][2][3].

   

ETHYL 2-(((1S,2R)-2-HYDROXY-1,2-DIPHENYLETHYL)AMINO)ACETATE

ETHYL 2-(((1S,2R)-2-HYDROXY-1,2-DIPHENYLETHYL)AMINO)ACETATE

C18H21NO3 (299.1521)


   

N2-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)PYRIMIDINE-2,5-DIAMINE

N2-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)PYRIMIDINE-2,5-DIAMINE

C16H21N5O (299.1746)


   
   
   
   

2-(dimethylamino)ethyl 2-methylprop-2-enoate,2-methylpropyl 2-methylprop-2-enoate

2-(dimethylamino)ethyl 2-methylprop-2-enoate,2-methylpropyl 2-methylprop-2-enoate

C16H29NO4 (299.2096)


   

ETHYL 2-(((1R,2S)-2-HYDROXY-1,2-DIPHENYLETHYL)AMINO)ACETATE

ETHYL 2-(((1R,2S)-2-HYDROXY-1,2-DIPHENYLETHYL)AMINO)ACETATE

C18H21NO3 (299.1521)


   

5-BOC-1-PHENYL-1,4,6,7-TETRAHYDROPYRAZOLO[4,3-C]PYRIDINE

5-BOC-1-PHENYL-1,4,6,7-TETRAHYDROPYRAZOLO[4,3-C]PYRIDINE

C17H21N3O2 (299.1634)


   

1-BOC-3-(3-MORPHOLIN-4-YL-PROPYLAMINO)-AZETIDINE

1-BOC-3-(3-MORPHOLIN-4-YL-PROPYLAMINO)-AZETIDINE

C15H29N3O3 (299.2209)


   

Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N,N-dimethyl- (9CI)

Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N,N-dimethyl- (9CI)

C17H21N3O2 (299.1634)


   

4-(2-ETHOXYCARBONYL-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(2-ETHOXYCARBONYL-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H25NO5 (299.1733)


   

Pyrrolidine,3-(diphenylmethylene)-1-ethyl-, hydrochloride (1:1)

Pyrrolidine,3-(diphenylmethylene)-1-ethyl-, hydrochloride (1:1)

C19H22ClN (299.1441)


   

Desvenlafaxine hydrochloride

Desvenlafaxine hydrochloride

C16H26ClNO2 (299.1652)


   

1-[1-(4-methoxyphenyl)-2-(methylamino)ethyl]cyclohexan-1-ol,hydrochloride

1-[1-(4-methoxyphenyl)-2-(methylamino)ethyl]cyclohexan-1-ol,hydrochloride

C16H26ClNO2 (299.1652)


   
   

hexyl (NZ)-N-[amino-(4-aminophenyl)methylidene]carbamate,hydrochloride

hexyl (NZ)-N-[amino-(4-aminophenyl)methylidene]carbamate,hydrochloride

C14H22ClN3O2 (299.14)


   

1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBONITRILE

1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBONITRILE

C17H25N3Si (299.1818)


   

TRAMADOL HYDROCHLORIDE

(+)-Tramadol Hydrochloride

C16H26ClNO2 (299.1652)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-[N-(2-hydroxyethyl)-4-(2-methoxyethylamino)-3-nitroanilino]ethanol

2-[N-(2-hydroxyethyl)-4-(2-methoxyethylamino)-3-nitroanilino]ethanol

C13H21N3O5 (299.1481)


   

tert-butyl 3-(2-ethoxy-2-oxoacetyl)-4-oxopiperidine-1-carboxylate

tert-butyl 3-(2-ethoxy-2-oxoacetyl)-4-oxopiperidine-1-carboxylate

C14H21NO6 (299.1369)


   

1-benzyl-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester

1-benzyl-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester

C18H26BNO2 (299.2056)


   

1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine

1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine

C18H26BNO2 (299.2056)


   

(S)-[1-([1,4]DIAZEPANE-1-CARBONYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER

(S)-[1-([1,4]DIAZEPANE-1-CARBONYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER

C15H29N3O3 (299.2209)


   

3-Ethyl 1-(2-methyl-2-propanyl) 3-isopropyl-1,3-piperidinedicarbo xylate

3-Ethyl 1-(2-methyl-2-propanyl) 3-isopropyl-1,3-piperidinedicarbo xylate

C16H29NO4 (299.2096)


   

Piperazine, 1-[(3-formyl-2-methyl-1H-indol-1-yl)acetyl]-4-methyl- (9CI)

Piperazine, 1-[(3-formyl-2-methyl-1H-indol-1-yl)acetyl]-4-methyl- (9CI)

C17H21N3O2 (299.1634)


   

Protriptyline hydrochloride

Protriptyline hydrochloride

C19H22ClN (299.1441)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   

Butyl 2-methyl-2-propenoate, N-[(2-methylpropoxy)methyl]-2-propenamide polymer

Butyl 2-methyl-2-propenoate, N-[(2-methylpropoxy)methyl]-2-propenamide polymer

C16H29NO4 (299.2096)


   

butyl prop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enamide

butyl prop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enamide

C15H25NO5 (299.1733)


   

1-Boc-2-[4-(2-pyridinyl)benzylidene]hydrazine

1-Boc-2-[4-(2-pyridinyl)benzylidene]hydrazine

C17H21N3O2 (299.1634)


   

Azepino[4,5-b]indole-5-carboxylic acid, 9-amino-1,2,3,6-tetrahydro-1,1-dimethyl-, ethyl ester

Azepino[4,5-b]indole-5-carboxylic acid, 9-amino-1,2,3,6-tetrahydro-1,1-dimethyl-, ethyl ester

C17H21N3O2 (299.1634)


   

n,n-dibenzyl-l-serine methyl ester

n,n-dibenzyl-l-serine methyl ester

C18H21NO3 (299.1521)


   

BENZYL 9-OXO-3-AZASPIRO[5.5]UNDEC-7-ENE-3-CARBOXYLATE

BENZYL 9-OXO-3-AZASPIRO[5.5]UNDEC-7-ENE-3-CARBOXYLATE

C18H21NO3 (299.1521)


   

2-Methyl-2-propanyl 4-(1H-pyrrolo[3,2-b]pyridin-3-yl)-3,6-dihydro -1(2H)-pyridinecarboxylate

2-Methyl-2-propanyl 4-(1H-pyrrolo[3,2-b]pyridin-3-yl)-3,6-dihydro -1(2H)-pyridinecarboxylate

C17H21N3O2 (299.1634)


   

4-[(1-ADAMANTYLCARBONYL)AMINO]BENZOIC ACID

4-[(1-ADAMANTYLCARBONYL)AMINO]BENZOIC ACID

C18H21NO3 (299.1521)


   

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)(4-phenyl-1-piperazinyl)

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)(4-phenyl-1-piperazinyl)

C17H21N3O2 (299.1634)


   

1-Oxa-8-azaspiro[4.5]decane-3-acetic acid, 8-[(1,1-dimethylethoxy)carbonyl]-

1-Oxa-8-azaspiro[4.5]decane-3-acetic acid, 8-[(1,1-dimethylethoxy)carbonyl]-

C15H25NO5 (299.1733)


   

Methyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate

Methyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate

C14H21NO6 (299.1369)


   

3,3-DIMETHOXY-ALPHA-METHYLDIPHENETHYLAMINE HYDROCHLORIDE

3,3-DIMETHOXY-ALPHA-METHYLDIPHENETHYLAMINE HYDROCHLORIDE

C19H25NO2 (299.1885)


   

(S)-ethyl 2-(tert-butoxycarbonylamino)non-8-enoate

(S)-ethyl 2-(tert-butoxycarbonylamino)non-8-enoate

C16H29NO4 (299.2096)


   

Ethyl 1-Boc-4-iso-propyl-4-piperidinecarboxylate

Ethyl 1-Boc-4-iso-propyl-4-piperidinecarboxylate

C16H29NO4 (299.2096)


   

7-Boc-3-phenyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine

7-Boc-3-phenyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine

C17H21N3O2 (299.1634)


   
   

5-(4-fluorophenyl)pyridine-3-boronic acid pinacol ester

5-(4-fluorophenyl)pyridine-3-boronic acid pinacol ester

C17H19BFNO2 (299.1493)


   

5-METHYL-2-((3-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE

5-METHYL-2-((3-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE

C16H21N5O (299.1746)


   

TRIMETHYL[3-(TRIETHOXYSILYL)PROPYL]AMMONIUM CHLORIDE

TRIMETHYL[3-(TRIETHOXYSILYL)PROPYL]AMMONIUM CHLORIDE

C12H30ClNO3Si (299.1683)


   

TERT-BUTYL 3-PHENYL-6,7-DIHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE-5(4H)-CARBOXYLATE

TERT-BUTYL 3-PHENYL-6,7-DIHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE-5(4H)-CARBOXYLATE

C17H21N3O2 (299.1634)


   

PHTHALIMIDE DBU SALT

PHTHALIMIDE DBU SALT

C17H21N3O2 (299.1634)


   

6-[4-[2-(dimethylamino)ethyl]-5-ethyl-2-methoxyphenyl]pyridin-2-amine

6-[4-[2-(dimethylamino)ethyl]-5-ethyl-2-methoxyphenyl]pyridin-2-amine

C18H25N3O (299.1998)


   

Metopon

(4R,4aR,7aR,12bS)-9-hydroxy-3,7a-dimethyl-2,4,4a,5,6,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one

C18H21NO3 (299.1521)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

1-benzhydryl-3-phenylazetidine

1-benzhydryl-3-phenylazetidine

C22H21N (299.1674)


   

3-[2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine

3-[2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine

C17H19BFNO2 (299.1493)


   

Melperone hydrochloride

Melperone hydrochloride

C16H23ClFNO (299.1452)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

[4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate

[4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate

C15H17N5O2 (299.1382)


   

(R)-(7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone

(R)-(7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone

C16H21N5O (299.1746)


   

2,6,14-Triaminotriptycene

2,6,14-Triaminotriptycene

C20H17N3 (299.1422)


   

9-(4-(tert-butyl)phenyl)-9H-carbazole

9-(4-(tert-butyl)phenyl)-9H-carbazole

C22H21N (299.1674)


   

(S)-2-{[(((1R,2R)-2-(allyloxy)cyclopentyl)oxy)carbonyl]amino}-3,3-dimethylbutanoic acid

(S)-2-{[(((1R,2R)-2-(allyloxy)cyclopentyl)oxy)carbonyl]amino}-3,3-dimethylbutanoic acid

C15H25NO5 (299.1733)


   

7-(5-Ethyl-2-nonanyl)-8-quinolinol

7-(5-Ethyl-2-nonanyl)-8-quinolinol

C20H29NO (299.2249)


   

3-(2-ethoxycarbonyl-acetyl)-piperidine-1-carboxylic acid tert-butyl ester

3-(2-ethoxycarbonyl-acetyl)-piperidine-1-carboxylic acid tert-butyl ester

C15H25NO5 (299.1733)


   

Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-(decyloxy)-, ammonium salt

Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-(decyloxy)-, ammonium salt

C12H29NO5S (299.1766)


   
   

6-(4-Fluorophenyl)pyridine-3-boronic acid pinacol ester

6-(4-Fluorophenyl)pyridine-3-boronic acid pinacol ester

C17H19BFNO2 (299.1493)


   

3-HYDROXY-N-((S)-2-OXOTETRAHYDROFURAN-3-YL)DODECANAMIDE

3-HYDROXY-N-((S)-2-OXOTETRAHYDROFURAN-3-YL)DODECANAMIDE

C16H29NO4 (299.2096)


   

9-(4-Hydroxybutyl)-N2-phenylguanine

9-(4-Hydroxybutyl)-N2-phenylguanine

C15H17N5O2 (299.1382)


   

4-Carboxy-5-(1-pentyl)hexylsulfanyl-1,2,3-triazole

4-Carboxy-5-(1-pentyl)hexylsulfanyl-1,2,3-triazole

C14H25N3O2S (299.1667)


   

Emixustat hydrochloride

Emixustat hydrochloride

C16H26ClNO2 (299.1652)


C78283 - Agent Affecting Organs of Special Senses

   

2-[(3S)-3-carboxy-3-(trimethylammonio)propyl]-L-histidine

2-[(3S)-3-carboxy-3-(trimethylammonio)propyl]-L-histidine

C13H23N4O4+ (299.1719)


   

Retinamide

Retinamide

C20H29NO (299.2249)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D000970 - Antineoplastic Agents

   

3-Cyclopropylmethyl-5-ethyl-8-hydroxy-11-methyl-3,4,5,6-tetrahydro-2H-2,6-methano-benzo[d]azocin-1-one

3-Cyclopropylmethyl-5-ethyl-8-hydroxy-11-methyl-3,4,5,6-tetrahydro-2H-2,6-methano-benzo[d]azocin-1-one

C19H25NO2 (299.1885)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

4-(Dipropylamino)-1,3,4,5-tetrahydrobenz(cd)indole-6-carboxamide

4-(Dipropylamino)-1,3,4,5-tetrahydrobenz(cd)indole-6-carboxamide

C18H25N3O (299.1998)


   

(2S)-2-[[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoic acid

(2S)-2-[[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoic acid

C14H25N3O4 (299.1845)


   

2-[[6-Amino-2-[3-(dimethylamino)propylamino]-5-nitro-4-pyrimidinyl]amino]ethanol

2-[[6-Amino-2-[3-(dimethylamino)propylamino]-5-nitro-4-pyrimidinyl]amino]ethanol

C11H21N7O3 (299.1706)


   

Arginine beta-naphthylamide

Arginine beta-naphthylamide

C16H21N5O (299.1746)


   

L-Proline, L-seryl-L-prolyl-

L-Proline, L-seryl-L-prolyl-

C13H21N3O5 (299.1481)


   

1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-(4,6-dimethyl-2-pyrimidinyl)guanidine

1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-(4,6-dimethyl-2-pyrimidinyl)guanidine

C15H17N5O2 (299.1382)


   

1-Cyclohexyl-3-[(1,2-dimethyl-5-indolyl)methyl]urea

1-Cyclohexyl-3-[(1,2-dimethyl-5-indolyl)methyl]urea

C18H25N3O (299.1998)


   

N,N-diethyl-2-(4-methyl-1-piperazinyl)-4-quinazolinamine

N,N-diethyl-2-(4-methyl-1-piperazinyl)-4-quinazolinamine

C17H25N5 (299.211)


   

N-[2-(3,4-dimethoxyphenyl)ethyl]-9H-purin-6-amine

N-[2-(3,4-dimethoxyphenyl)ethyl]-9H-purin-6-amine

C15H17N5O2 (299.1382)


   

N-(2-((4-Methoxybenzyl)(2-pyridinyl)amino)ethyl)-N-methylformamide

N-(2-((4-Methoxybenzyl)(2-pyridinyl)amino)ethyl)-N-methylformamide

C17H21N3O2 (299.1634)


   

3-(4-Dimethylaminophenyl)benzo[f]quinazoline

3-(4-Dimethylaminophenyl)benzo[f]quinazoline

C20H17N3 (299.1422)


   

2-(beta-Dimethylaminopropionyl)-5,7-dimethyl-1,2,3,4-tetrahydropyrimido(3,4-a)indole

2-(beta-Dimethylaminopropionyl)-5,7-dimethyl-1,2,3,4-tetrahydropyrimido(3,4-a)indole

C18H25N3O (299.1998)


   

AIDS-226940

7-Isoquinolinol, 1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-, (1R)-

C18H21NO3 (299.1521)


   

Codein

Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)- (9CI)

C18H21NO3 (299.1521)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

N-(3,5-dimethylphenyl)-2-(4-ethoxyphenoxy)acetamide

N-(3,5-dimethylphenyl)-2-(4-ethoxyphenoxy)acetamide

C18H21NO3 (299.1521)


   

2,11-dimethoxy-2,6,8,9-tetrahydro-1H-indolo[7a,1-a]isoquinolin-12-ol

2,11-dimethoxy-2,6,8,9-tetrahydro-1H-indolo[7a,1-a]isoquinolin-12-ol

C18H21NO3 (299.1521)


   

[(1S,7aR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl 2,3-dihydroxy-2-(propan-2-yl)butanoate

[(1S,7aR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl 2,3-dihydroxy-2-(propan-2-yl)butanoate

C15H25NO5 (299.1733)


   

all-trans-Retinoate

all-trans-Retinoate

C20H27O2- (299.2011)


A retinoate that is the conjugate base of all-trans-retinoic acid.

   

fumigaclavine A(1+)

fumigaclavine A(1+)

C18H23N2O2+ (299.1759)


An ammonium ion obtained by the protonation of the tertiary amino group of fumigaclavine A; major species at pH 7.3.

   

3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate

3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate

C20H27O2- (299.2011)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

13-cis-Retinoate

13-cis-Retinoate

C20H27O2- (299.2011)


   

(1R,4aS)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate

(1R,4aS)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate

C20H27O2- (299.2011)


   

(S,S)-2,5-di-(p-hydroxybenzyl)piperazine

(S,S)-2,5-di-(p-hydroxybenzyl)piperazine

C18H23N2O2+ (299.1759)


   

Tyrosamine beta-D-glucoside

Tyrosamine beta-D-glucoside

C14H21NO6 (299.1369)


   

(2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate

(2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate

C20H27O2- (299.2011)


   

(2S)-5-oxo-5-[[(3S)-2-oxopiperidin-3-yl]amino]-2-(propanoylamino)pentanoic acid

(2S)-5-oxo-5-[[(3S)-2-oxopiperidin-3-yl]amino]-2-(propanoylamino)pentanoic acid

C13H21N3O5 (299.1481)


   

(2S)-2-[[(2E,6E)-8-hydroxy-3,7-dimethylocta-2,6-dienyl]amino]pentanedioic acid

(2S)-2-[[(2E,6E)-8-hydroxy-3,7-dimethylocta-2,6-dienyl]amino]pentanedioic acid

C15H25NO5 (299.1733)


   

2,3-dimethylidenepentanedioylcarnitine

2,3-dimethylidenepentanedioylcarnitine

C14H21NO6 (299.1369)


   

(4R,4Ar,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,7a,11a,12a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

(4R,4Ar,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,7a,11a,12a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

C18H21NO3 (299.1521)


   

Non-4-enoylcarnitine

Non-4-enoylcarnitine

C16H29NO4 (299.2096)


   

Non-5-enoylcarnitine

Non-5-enoylcarnitine

C16H29NO4 (299.2096)


   

Non-3-enoylcarnitine

Non-3-enoylcarnitine

C16H29NO4 (299.2096)


   

Non-7-enoylcarnitine

Non-7-enoylcarnitine

C16H29NO4 (299.2096)


   

Non-6-enoylcarnitine

Non-6-enoylcarnitine

C16H29NO4 (299.2096)


   

(2Z)-Non-2-enoylcarnitine

(2Z)-Non-2-enoylcarnitine

C16H29NO4 (299.2096)


   

3-Hydroxyocta-2,5-dienoylcarnitine

3-Hydroxyocta-2,5-dienoylcarnitine

C15H25NO5 (299.1733)


   

3-Hydroxyocta-2,6-dienoylcarnitine

3-Hydroxyocta-2,6-dienoylcarnitine

C15H25NO5 (299.1733)


   

3-Hydroxyocta-3,6-dienoylcarnitine

3-Hydroxyocta-3,6-dienoylcarnitine

C15H25NO5 (299.1733)


   

3-Hydroxyocta-2,4-dienoylcarnitine

3-Hydroxyocta-2,4-dienoylcarnitine

C15H25NO5 (299.1733)


   

3-Hydroxyocta-3,5-dienoylcarnitine

3-Hydroxyocta-3,5-dienoylcarnitine

C15H25NO5 (299.1733)


   

(4Z,6Z)-3-Hydroxyocta-4,6-dienoylcarnitine

(4Z,6Z)-3-Hydroxyocta-4,6-dienoylcarnitine

C15H25NO5 (299.1733)


   

1-[(2E,4E)-7-(3,4-methylenedioxyphenyl)-2,4-heptadienoyl]pyrrolidine

1-[(2E,4E)-7-(3,4-methylenedioxyphenyl)-2,4-heptadienoyl]pyrrolidine

C18H21NO3 (299.1521)


A natural product found in Piper boehmeriaefolium.

   

Streptoverticillin

Streptoverticillin

C18H21NO3 (299.1521)


A carbazole alkaloid that is 9H-carbazole substituted by a methyl group at position 2, methoxy groups at positions 3 and 4 and a (2S)-2-hydroxypropyl group at position 1. Isolated from mycelial solid culture of Streptoverticillium morookaense, it exhibits antifungal activity.

   

9-cis-Retinoate

9-cis-Retinoate

C20H27O2- (299.2011)


A retinoate that is the conjugate base of 9-cis-retinoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

1-(4-Tert-butylphenyl)-3-(3-pyridinylmethyl)thiourea

1-(4-Tert-butylphenyl)-3-(3-pyridinylmethyl)thiourea

C17H21N3S (299.1456)


   

11-cis-Retinoate

11-cis-Retinoate

C20H27O2- (299.2011)


A retinoate that is the conjugate base of 11-cis-retinoic acid, obtaained by deprotonation of the carboxy group; major species at pH 7.3.

   

(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate

(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate

C20H27O2- (299.2011)


   

N-acetyl-S-(e)-geranyl-l-cysteine

N-acetyl-S-(e)-geranyl-l-cysteine

C15H25NO3S (299.1555)


   

2-Methoxy-5-[(6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]phenol

2-Methoxy-5-[(6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]phenol

C18H21NO3 (299.1521)


   

(2R)-1-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

(2R)-1-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

C14H25N3O4 (299.1845)


   

N-(1-butyl-2-benzimidazolyl)cyclohexanecarboxamide

N-(1-butyl-2-benzimidazolyl)cyclohexanecarboxamide

C18H25N3O (299.1998)


   

N,N-dimethyl-2-[(2-phenyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)thio]ethanamine

N,N-dimethyl-2-[(2-phenyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)thio]ethanamine

C17H21N3S (299.1456)


   

3-(2-Furanyl)-3-(4-methylphenyl)-1-(4-morpholinyl)-1-propanone

3-(2-Furanyl)-3-(4-methylphenyl)-1-(4-morpholinyl)-1-propanone

C18H21NO3 (299.1521)


   

2-[2-[(1-Phenyl-4-pyrazolo[3,4-d]pyrimidinyl)amino]ethoxy]ethanol

2-[2-[(1-Phenyl-4-pyrazolo[3,4-d]pyrimidinyl)amino]ethoxy]ethanol

C15H17N5O2 (299.1382)


   

3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-aminium chloride

3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-aminium chloride

C19H22ClN (299.1441)


   

1-[2-(diethylamino)ethyl]-5,6-dimethyl-1H-pyrrolo[1,2,3-de]quinoxalin-2(3H)-one

1-[2-(diethylamino)ethyl]-5,6-dimethyl-1H-pyrrolo[1,2,3-de]quinoxalin-2(3H)-one

C18H25N3O (299.1998)


   

4-{2-[(2,4-Dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium

4-{2-[(2,4-Dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium

C18H23N2S+ (299.1582)


   

1-[4-[4-(2-Furanylmethylamino)phenyl]-1-piperazinyl]ethanone

1-[4-[4-(2-Furanylmethylamino)phenyl]-1-piperazinyl]ethanone

C17H21N3O2 (299.1634)


   
   
   
   
   

4-Aza-17-oxoestra-1,3,5(10)-triene-3-carboxylic acid

4-Aza-17-oxoestra-1,3,5(10)-triene-3-carboxylic acid

C18H21NO3 (299.1521)


   
   
   
   
   
   
   
   

Isoleucyl-alanyl-proline

Isoleucyl-alanyl-proline

C14H25N3O4 (299.1845)


   

(S)-carazolol(1+)

(S)-carazolol(1+)

C18H23N2O2+ (299.1759)


   

(E)-Delta-methoxymycolate

(E)-Delta-methoxymycolate

C17H31O4- (299.2222)


   

2,6-Ditert-butyl-4-(4-methoxyphenyl)pyrylium

2,6-Ditert-butyl-4-(4-methoxyphenyl)pyrylium

C20H27O2+ (299.2011)


   

3-(Diethylamino)-1-(4-fluorophenyl)-2-phenyl-1-propanone

3-(Diethylamino)-1-(4-fluorophenyl)-2-phenyl-1-propanone

C19H22FNO (299.1685)


   

5,5-Dimethyl-2-[(E)-3-(4-methylanilino)prop-2-enoyl]cyclohexane-1,3-dione

5,5-Dimethyl-2-[(E)-3-(4-methylanilino)prop-2-enoyl]cyclohexane-1,3-dione

C18H21NO3 (299.1521)


   

Propan-2-yl 5-methyl-7-pyridin-3-yl-6,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate

Propan-2-yl 5-methyl-7-pyridin-3-yl-6,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate

C15H17N5O2 (299.1382)


   

cyclo-(D-Leu-L-Trp)

cyclo-(D-Leu-L-Trp)

C17H21N3O2 (299.1634)


   

(3R,6S)-3-butan-2-yl-6-(1H-indol-3-ylmethyl)piperazine-2,5-dione

(3R,6S)-3-butan-2-yl-6-(1H-indol-3-ylmethyl)piperazine-2,5-dione

C17H21N3O2 (299.1634)


   

2-Aminoethyl (3-hexoxy-2-hydroxypropyl) hydrogen phosphate

2-Aminoethyl (3-hexoxy-2-hydroxypropyl) hydrogen phosphate

C11H26NO6P (299.1498)


   

(2-Hydroxy-3-propoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hydroxy-3-propoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C11H26NO6P (299.1498)


   

Propanoic acid, 2-[(1-cyclohexylethyl)carbamoyl]-, trimethylsilyl ester

Propanoic acid, 2-[(1-cyclohexylethyl)carbamoyl]-, trimethylsilyl ester

C15H29NO3Si (299.1917)


   

(4aR,7S,7aR,12bS)-3,11-dimethyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol

(4aR,7S,7aR,12bS)-3,11-dimethyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol

C18H21NO3 (299.1521)


   

(S)-N-Methylcoclaurine

(S)-N-Methylcoclaurine

C18H21NO3 (299.1521)


The (S)-enantiomer of N-methylcoclaurine.

   

Neopine

Neopine

C18H21NO3 (299.1521)


A morphinane alkaloid that is the Delta(8,14) isomer of codeine. It is a minor constituent in opium from Papaver somniferum. D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

CID 443409

CID 443409

C19H25NO2 (299.1885)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

3-Hydroxyestra-1,3,5(10)-triene-16,17-dione 16-oxime

3-Hydroxyestra-1,3,5(10)-triene-16,17-dione 16-oxime

C18H21NO3 (299.1521)


   

Thiazinamium

Thiazinamium

C18H23N2S+ (299.1582)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Diphthine

Diphthine

C13H23N4O4 (299.1719)


A quaternary ammonium ion consisting of L-histidine with a 3-(trimethylammonio)-3-carboxypropyl group at the 2-position of the the imidazole ring.

   

BTCP HCl

1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine

C19H25NS (299.1708)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

2-Undecyl-4(1H)-quinolinone

2-Undecyl-4(1H)-quinolinone

C20H29NO (299.2249)


   

2-(3-carboxy-3-(trimethylammonio)propyl)-L-histidine

2-(3-carboxy-3-(trimethylammonio)propyl)-L-histidine

C13H23N4O4+ (299.1719)


   

Dicodid

Dicodid

C18H21NO3 (299.1521)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

3-Hydroxy-N-(2-oxotetrahydrofuran-3-yl)dodecanamide

3-Hydroxy-N-(2-oxotetrahydrofuran-3-yl)dodecanamide

C16H29NO4 (299.2096)


   

pyridinestrone-3-carboxylic acid

pyridinestrone-3-carboxylic acid

C18H21NO3 (299.1521)


An aza-steroid that is 17-oxoestra-1,3,5(10)-triene-3-carboxylic acid in which the carbon at position 4 in the A-ring has been replaced by a nitrogen. An abiotic metabolite in the 4,5-seco pathway of aerobic estrogen degradation by the bacterium Sphingomonas sp. strain KC8.

   

Dehydroabietate

Dehydroabietate

C20H27O2 (299.2011)


A monocarboxylic acid anion that is the conjugate base of dehydroabietic acid, obtained by deprotonation of the carboxy group.

   
   
   
   
   
   
   
   
   

Undecyl-(1H-quinolinone)

Undecyl-(1H-quinolinone)

C20H29NO (299.2249)


   

U93631

U93631

C17H21N3O2 (299.1634)


U93631 is a GABAA receptor ligand of novel chemical structure with IC50 of 100 nM,and has been shown to induce a rapid, time-dependent decay of GABA-induced whole-cell Cl-currents in recombinant GABAA receptors. target: GABAA receptor IC 50: GABAA receptor[1] In vitro: In the presence of U93631 at 5 UM, the peak amplitude decreased as a function of GABA concentration, with the half-maximal inhibitory concentration being approximately 100 nM, which is close to the Kd for the high affinity GABA site(85 nM). It appears that the drug interacts with GABA-bound receptors (at least monoliganded) and accelerates receptor desensitization, rather than acting as an open channel blocker. [1]

   

(1r,7ar)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

(1r,7ar)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO5 (299.1733)


   

4-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

4-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

C20H17N3 (299.1422)


   

(1s,19s)-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraene

(1s,19s)-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraene

C18H21NO3 (299.1521)


   

3-(3-{9h-pyrido[3,4-b]indol-1-yl}phenyl)prop-2-en-1-amine

3-(3-{9h-pyrido[3,4-b]indol-1-yl}phenyl)prop-2-en-1-amine

C20H17N3 (299.1422)


   

(9bs,11r)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

(9bs,11r)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

C18H21NO3 (299.1521)


   

(1r)-6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-7-ol

(1r)-6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-7-ol

C18H21NO3 (299.1521)


   

4-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]phenol

4-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]phenol

C18H21NO3 (299.1521)


   

(2s,4e,6e,11e)-12-(pyridin-3-yl)dodeca-4,6,11-trien-2-yl acetate

(2s,4e,6e,11e)-12-(pyridin-3-yl)dodeca-4,6,11-trien-2-yl acetate

C19H25NO2 (299.1885)


   

[(7s,7as)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

[(7s,7as)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO5 (299.1733)


   

2-decyl-1-methylquinolin-4-one

2-decyl-1-methylquinolin-4-one

C20H29NO (299.2249)


   

(2e,6e,8e)-1-(pyrrolidin-1-yl)hexadeca-2,6,8-trien-10-yn-1-one

(2e,6e,8e)-1-(pyrrolidin-1-yl)hexadeca-2,6,8-trien-10-yn-1-one

C20H29NO (299.2249)


   

1-(3,4-dimethoxy-2-methyl-9h-carbazol-1-yl)propan-2-ol

1-(3,4-dimethoxy-2-methyl-9h-carbazol-1-yl)propan-2-ol

C18H21NO3 (299.1521)


   

(3s,6r)-3-(1h-indol-3-ylmethyl)-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol

(3s,6r)-3-(1h-indol-3-ylmethyl)-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol

C17H21N3O2 (299.1634)


   

(2e,6e,8e,12z)-n-(2-methylpropyl)hexadeca-2,6,8,12-tetraen-10-ynimidic acid

(2e,6e,8e,12z)-n-(2-methylpropyl)hexadeca-2,6,8,12-tetraen-10-ynimidic acid

C20H29NO (299.2249)


   

(2s,4e,6e,8e)-12-(pyridin-3-yl)dodeca-4,6,8-trien-2-yl acetate

(2s,4e,6e,8e)-12-(pyridin-3-yl)dodeca-4,6,8-trien-2-yl acetate

C19H25NO2 (299.1885)


   

6-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

6-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

C20H17N3 (299.1422)


   

(1s,10s,11s)-1,7,10,11-tetramethyl-2-oxa-15-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-3(8),4,6-trien-9-one

(1s,10s,11s)-1,7,10,11-tetramethyl-2-oxa-15-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-3(8),4,6-trien-9-one

C19H25NO2 (299.1885)


   

1,7,10,11-tetramethyl-2-oxa-15-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-3(8),4,6-trien-9-one

1,7,10,11-tetramethyl-2-oxa-15-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-3(8),4,6-trien-9-one

C19H25NO2 (299.1885)


   

2-(nonan-8-one)-4-methoxy-quinoline

NA

C19H25NO2 (299.1885)


{"Ingredient_id": "HBIN006130","Ingredient_name": "2-(nonan-8-one)-4-methoxy-quinoline","Alias": "NA","Ingredient_formula": "C19H25NO2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15680","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-(nonan-8-one)-n-methyl-4-quinolone

NA

C19H25NO2 (299.1885)


{"Ingredient_id": "HBIN006131","Ingredient_name": "2-(nonan-8-one)-n-methyl-4-quinolone","Alias": "NA","Ingredient_formula": "C19H25NO2","Ingredient_Smile": "CCCCCCC=CCC1=C(C(=O)C2=CC=CC=C2N1O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15681","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(+)-8,9-dihydrostepharine

NA

C18H21NO3 (299.1521)


{"Ingredient_id": "HBIN013591","Ingredient_name": "(+)-8,9-dihydrostepharine","Alias": "NA","Ingredient_formula": "C18H21NO3","Ingredient_Smile": "COC1=C(C2=C3C(CC24CCC(=O)C=C4)NCCC3=C1)OC","Ingredient_weight": "299.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5718","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "13819281","DrugBank_id": "NA"}

   

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-1h-pyrrolizin-1-yl]methyl (2r)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-1h-pyrrolizin-1-yl]methyl (2r)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO5 (299.1733)


   

11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-6-ol

11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-6-ol

C20H29NO (299.2249)


   

2-undecyl-3h-quinolin-4-one

2-undecyl-3h-quinolin-4-one

C20H29NO (299.2249)


   

11'-hydroxy-10'-methoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

11'-hydroxy-10'-methoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C18H21NO3 (299.1521)


   

4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12,17,19-octaene

4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12,17,19-octaene

C20H17N3 (299.1422)


   

(1s,4'r)-11'-hydroxy-10'-methoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

(1s,4'r)-11'-hydroxy-10'-methoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C18H21NO3 (299.1521)


   

3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]-1-(1h-pyrrol-2-yl)penta-2,4-dien-1-one

3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]-1-(1h-pyrrol-2-yl)penta-2,4-dien-1-one

C19H25NO2 (299.1885)


   
   

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s,3s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylpentanoate

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s,3s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylpentanoate

C16H29NO4 (299.2096)


   

(2e,4e)-7-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)hepta-2,4-dien-1-one

(2e,4e)-7-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)hepta-2,4-dien-1-one

C18H21NO3 (299.1521)


   

8,11-dimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

8,11-dimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

C18H21NO3 (299.1521)


   

(1r)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

(1r)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

C18H21NO3 (299.1521)


   

(2z)-3-(3-{9h-pyrido[3,4-b]indol-1-yl}phenyl)prop-2-en-1-amine

(2z)-3-(3-{9h-pyrido[3,4-b]indol-1-yl}phenyl)prop-2-en-1-amine

C20H17N3 (299.1422)


   

7,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-8-ol

7,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-8-ol

C18H21NO3 (299.1521)


   

(2e,9z)-n-(2-methylpropyl)hexadeca-2,9-dien-12,14-diynimidic acid

(2e,9z)-n-(2-methylpropyl)hexadeca-2,9-dien-12,14-diynimidic acid

C20H29NO (299.2249)


   

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r,3s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylpentanoate

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r,3s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylpentanoate

C16H29NO4 (299.2096)


   

(1r,4's)-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

(1r,4's)-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C18H21NO3 (299.1521)


   

5-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

5-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

C20H17N3 (299.1422)


   

1-[(3-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

1-[(3-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

C18H21NO3 (299.1521)


   

(3r)-3-[(2s)-butan-2-yl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3r)-3-[(2s)-butan-2-yl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C17H21N3O2 (299.1634)


   

n-(2-methylpropyl)hexadeca-2,9-dien-12,14-diynimidic acid

n-(2-methylpropyl)hexadeca-2,9-dien-12,14-diynimidic acid

C20H29NO (299.2249)


   

1-[4-(4-methyl-5-oxofuran-2-ylidene)butyl]-6-methylidene-2h,3h,4h,7h-cyclopenta[b]pyridin-5-one

1-[4-(4-methyl-5-oxofuran-2-ylidene)butyl]-6-methylidene-2h,3h,4h,7h-cyclopenta[b]pyridin-5-one

C18H21NO3 (299.1521)


   

(1r,10s,11s)-1,7,10,11-tetramethyl-2-oxa-15-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-3(8),4,6-trien-9-one

(1r,10s,11s)-1,7,10,11-tetramethyl-2-oxa-15-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-3(8),4,6-trien-9-one

C19H25NO2 (299.1885)


   

(2e,4e,6e)-12-(pyridin-3-yl)dodeca-2,4,6-trien-1-yl acetate

(2e,4e,6e)-12-(pyridin-3-yl)dodeca-2,4,6-trien-1-yl acetate

C19H25NO2 (299.1885)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-n,3-dimethylbut-2-enamide

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-n,3-dimethylbut-2-enamide

C19H25NO2 (299.1885)


   

12-(pyridin-3-yl)dodeca-4,6,8-trien-2-yl acetate

12-(pyridin-3-yl)dodeca-4,6,8-trien-2-yl acetate

C19H25NO2 (299.1885)


   

n-(2-methylpropyl)hexadeca-2,6,8,12-tetraen-10-ynimidic acid

n-(2-methylpropyl)hexadeca-2,6,8,12-tetraen-10-ynimidic acid

C20H29NO (299.2249)


   

(1s)-6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-7-ol

(1s)-6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-7-ol

C18H21NO3 (299.1521)


   

(1s,2s,4s,6r,7s,10r,11r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-6-ol

(1s,2s,4s,6r,7s,10r,11r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-6-ol

C20H29NO (299.2249)


   

(2e,6z,8e,12z)-n-(2-methylpropyl)hexadeca-2,6,8,12-tetraen-10-ynimidic acid

(2e,6z,8e,12z)-n-(2-methylpropyl)hexadeca-2,6,8,12-tetraen-10-ynimidic acid

C20H29NO (299.2249)


   

19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraene

19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraene

C18H21NO3 (299.1521)


   

[(7s,7as)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

[(7s,7as)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO5 (299.1733)


   

[4,5-dimethoxy-2-(1-methyl-2,3-dihydroindol-7-yl)phenyl]methanol

[4,5-dimethoxy-2-(1-methyl-2,3-dihydroindol-7-yl)phenyl]methanol

C18H21NO3 (299.1521)


   

( )-intermedine

( )-intermedine

C15H25NO5 (299.1733)


   

(1s)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-ol

(1s)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-ol

C18H21NO3 (299.1521)


   

(1s)-1-[(3-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

(1s)-1-[(3-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

C18H21NO3 (299.1521)


   

10'-hydroxy-11'-methoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),2,8',10'-tetraen-4-one

10'-hydroxy-11'-methoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),2,8',10'-tetraen-4-one

C18H21NO3 (299.1521)


   

4-{[(1r)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenol

4-{[(1r)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenol

C18H21NO3 (299.1521)


   

6-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

6-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

C20H17N3 (299.1422)


   

(1s)-6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

(1s)-6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

C18H21NO3 (299.1521)


   

(1s,4'r)-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

(1s,4'r)-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C18H21NO3 (299.1521)


   

(2z,6z,8z,12e)-n-(2-methylpropyl)hexadeca-2,6,8,12-tetraen-10-ynimidic acid

(2z,6z,8z,12e)-n-(2-methylpropyl)hexadeca-2,6,8,12-tetraen-10-ynimidic acid

C20H29NO (299.2249)


   

(1r,15s,16s,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12,17,19-octaene

(1r,15s,16s,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12,17,19-octaene

C20H17N3 (299.1422)


   

(7as)-1-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

(7as)-1-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

C15H25NO5 (299.1733)


   

(1s,5r,14r)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),16-tetraen-14-ol

(1s,5r,14r)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),16-tetraen-14-ol

C18H21NO3 (299.1521)


   

3-(1h-indol-3-ylmethyl)-6-(sec-butyl)-3,6-dihydropyrazine-2,5-diol

3-(1h-indol-3-ylmethyl)-6-(sec-butyl)-3,6-dihydropyrazine-2,5-diol

C17H21N3O2 (299.1634)


   

2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

C20H17N3 (299.1422)


   

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r,3s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylpentanoate

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r,3s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylpentanoate

C16H29NO4 (299.2096)


   

(1s,4s,12'r)-11'-methyl-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),7'-tetraen-4-ol

(1s,4s,12'r)-11'-methyl-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),7'-tetraen-4-ol

C18H21NO3 (299.1521)


   

9-(4-methoxyquinolin-2-yl)nonan-2-one

9-(4-methoxyquinolin-2-yl)nonan-2-one

C19H25NO2 (299.1885)


   

(9bs,11r)-7,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-8-ol

(9bs,11r)-7,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-8-ol

C18H21NO3 (299.1521)


   

2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

C20H17N3 (299.1422)


   

(2s,5e,8e,10e)-12-(pyridin-3-yl)dodeca-5,8,10-trien-2-yl acetate

(2s,5e,8e,10e)-12-(pyridin-3-yl)dodeca-5,8,10-trien-2-yl acetate

C19H25NO2 (299.1885)


   

4-{[(1s)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenol

4-{[(1s)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenol

C18H21NO3 (299.1521)


   

7-methoxy-2-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-6-ol

7-methoxy-2-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-6-ol

C18H21NO3 (299.1521)


   

(1r,9s,10s)-5-hydroxy-3-methoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5,13-tetraen-12-one

(1r,9s,10s)-5-hydroxy-3-methoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5,13-tetraen-12-one

C18H21NO3 (299.1521)


   

5-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

5-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

C20H17N3 (299.1422)


   

4-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

4-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

C20H17N3 (299.1422)


   

10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C18H21NO3 (299.1521)


   

(1s,2s,4s,6r,7s,10s,11r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-12-en-6-ol

(1s,2s,4s,6r,7s,10s,11r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-12-en-6-ol

C20H29NO (299.2249)


   

1-methyl-2-(8-oxononyl)quinolin-4-one

1-methyl-2-(8-oxononyl)quinolin-4-one

C19H25NO2 (299.1885)


   

(2e,7z)-1-(2,3-dihydropyrrol-1-yl)hexadeca-2,7-dien-10-yn-1-one

(2e,7z)-1-(2,3-dihydropyrrol-1-yl)hexadeca-2,7-dien-10-yn-1-one

C20H29NO (299.2249)


   

1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

C18H21NO3 (299.1521)


   

12-(pyridin-3-yl)dodeca-5,8,10-trien-2-yl acetate

12-(pyridin-3-yl)dodeca-5,8,10-trien-2-yl acetate

C19H25NO2 (299.1885)


   

(1s,2s,4s,6s,7s,10s,11r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-12-en-6-ol

(1s,2s,4s,6s,7s,10s,11r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-12-en-6-ol

C20H29NO (299.2249)


   

(2z,4z)-7-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)hepta-2,4-dien-1-one

(2z,4z)-7-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)hepta-2,4-dien-1-one

C18H21NO3 (299.1521)


   

2-methyl-1betah-coclaurine

2-methyl-1betah-coclaurine

C18H21NO3 (299.1521)


   

(1s,4r,12r,15r)-15-ethyl-4-hydroxy-1λ⁵,11-diazapentacyclo[13.3.1.0¹,¹².0⁴,¹².0⁵,¹⁰]nonadeca-5,7,9-trien-1-ylium

(1s,4r,12r,15r)-15-ethyl-4-hydroxy-1λ⁵,11-diazapentacyclo[13.3.1.0¹,¹².0⁴,¹².0⁵,¹⁰]nonadeca-5,7,9-trien-1-ylium

[C19H27N2O]+ (299.2123)


   

(1s,2s,4s,6s,7s,10r,11r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-6-ol

(1s,2s,4s,6s,7s,10r,11r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-6-ol

C20H29NO (299.2249)


   

11'-methyl-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),7'-tetraen-4-ol

11'-methyl-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),7'-tetraen-4-ol

C18H21NO3 (299.1521)


   

1-(2,3-dihydropyrrol-1-yl)hexadeca-2,7-dien-10-yn-1-one

1-(2,3-dihydropyrrol-1-yl)hexadeca-2,7-dien-10-yn-1-one

C20H29NO (299.2249)


   

(7z)-1-(pyrrol-1-yl)hexadec-7-en-10-yn-1-one

(7z)-1-(pyrrol-1-yl)hexadec-7-en-10-yn-1-one

C20H29NO (299.2249)


   

(1r,4'r)-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

(1r,4'r)-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C18H21NO3 (299.1521)


   

6-methoxy-2-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-7-ol

6-methoxy-2-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-7-ol

C18H21NO3 (299.1521)


   

(3r,6s)-3-[(2s)-butan-2-yl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3r,6s)-3-[(2s)-butan-2-yl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C17H21N3O2 (299.1634)


   

8-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

8-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]quinoline

C20H17N3 (299.1422)


   

(1r)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-ol

(1r)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-ol

C18H21NO3 (299.1521)


   

7-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)hepta-2,4-dien-1-one

7-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)hepta-2,4-dien-1-one

C18H21NO3 (299.1521)


   

2,8-bis(acetyloxy)-octahydroindolizin-1-yl acetate

2,8-bis(acetyloxy)-octahydroindolizin-1-yl acetate

C14H21NO6 (299.1369)


   

5-hydroxy-3-methoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5,13-tetraen-12-one

5-hydroxy-3-methoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5,13-tetraen-12-one

C18H21NO3 (299.1521)


   

(1s,4'r)-10'-hydroxy-11'-methoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),2,8',10'-tetraen-4-one

(1s,4'r)-10'-hydroxy-11'-methoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),2,8',10'-tetraen-4-one

C18H21NO3 (299.1521)


   

9-(4-hydroxybutyl)-2-(phenylimino)-3h-purin-6-ol

9-(4-hydroxybutyl)-2-(phenylimino)-3h-purin-6-ol

C15H17N5O2 (299.1382)


   

(1r,7ar)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

(1r,7ar)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO5 (299.1733)


   

3-(1h-indol-3-ylmethyl)-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol

3-(1h-indol-3-ylmethyl)-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol

C17H21N3O2 (299.1634)


   

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-4-methylpentanoate

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-4-methylpentanoate

C16H29NO4 (299.2096)


   

1-(pyrrolidin-1-yl)hexadeca-2,6,8-trien-10-yn-1-one

1-(pyrrolidin-1-yl)hexadeca-2,6,8-trien-10-yn-1-one

C20H29NO (299.2249)


   

3-{[(1r)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenol

3-{[(1r)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenol

C18H21NO3 (299.1521)


   

hexahydro-1h-pyrrolizin-1-ylmethyl 2-hydroxy-2-(1-hydroxyethyl)-4-methylpentanoate

hexahydro-1h-pyrrolizin-1-ylmethyl 2-hydroxy-2-(1-hydroxyethyl)-4-methylpentanoate

C16H29NO4 (299.2096)


   

6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-7-ol

6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-7-ol

C18H21NO3 (299.1521)


   

8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-ol

8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-ol

C18H21NO3 (299.1521)


   

8-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

8-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

C20H17N3 (299.1422)


   

(2z,4e)-3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]-1-(1h-pyrrol-2-yl)penta-2,4-dien-1-one

(2z,4e)-3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]-1-(1h-pyrrol-2-yl)penta-2,4-dien-1-one

C19H25NO2 (299.1885)


   

2-[(4-butylphenyl)amino]-5-methoxy-3-methylcyclohexa-2,5-diene-1,4-dione

2-[(4-butylphenyl)amino]-5-methoxy-3-methylcyclohexa-2,5-diene-1,4-dione

C18H21NO3 (299.1521)


   

1-hydroxy-3-methyl-2-[(2e)-non-2-en-1-yl]quinolin-4-one

1-hydroxy-3-methyl-2-[(2e)-non-2-en-1-yl]quinolin-4-one

C19H25NO2 (299.1885)


   

15-ethyl-4-hydroxy-1λ⁵,11-diazapentacyclo[13.3.1.0¹,¹².0⁴,¹².0⁵,¹⁰]nonadeca-5,7,9-trien-1-ylium

15-ethyl-4-hydroxy-1λ⁵,11-diazapentacyclo[13.3.1.0¹,¹².0⁴,¹².0⁵,¹⁰]nonadeca-5,7,9-trien-1-ylium

[C19H27N2O]+ (299.2123)


   

1-hydroxy-3-methyl-2-(non-2-en-1-yl)quinolin-4-one

1-hydroxy-3-methyl-2-(non-2-en-1-yl)quinolin-4-one

C19H25NO2 (299.1885)


   

6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

C18H21NO3 (299.1521)


   

1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

C18H21NO3 (299.1521)


   

(1s,2r,8r,8ar)-1,8-bis(acetyloxy)-octahydroindolizin-2-yl acetate

(1s,2r,8r,8ar)-1,8-bis(acetyloxy)-octahydroindolizin-2-yl acetate

C14H21NO6 (299.1369)


   

1-(pyrrol-1-yl)hexadec-7-en-10-yn-1-one

1-(pyrrol-1-yl)hexadec-7-en-10-yn-1-one

C20H29NO (299.2249)


   

hexahydro-1h-pyrrolizin-1-ylmethyl 2-hydroxy-2-(1-hydroxyethyl)-3-methylpentanoate

hexahydro-1h-pyrrolizin-1-ylmethyl 2-hydroxy-2-(1-hydroxyethyl)-3-methylpentanoate

C16H29NO4 (299.2096)


   

7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2,3-dihydroxy-2-isopropylbutanoate

7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2,3-dihydroxy-2-isopropylbutanoate

C15H25NO5 (299.1733)